Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fungus – except allergen – or component thereof or substance...
Reexamination Certificate
2011-02-15
2011-02-15
Graser, Jennifer E (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Fungus, except allergen, or component thereof or substance...
C424S094100, C424S185100, C530S350000, C435S183000
Reexamination Certificate
active
07887820
ABSTRACT:
This document relates to methods and materials involved in fungus-induced inflammation and eosinophil degranulation. For example, isolated nucleic acids encoding fungal polypeptides, fungal polypeptides, methods for assessing fungus-induced inflammation, methods for assessing eosinophil degranulation, and methods for identifying inhibitors of fungus-induced inflammation and/or eosinophil degranulation are provided.
REFERENCES:
patent: 5538897 (1996-07-01), Yates, III et al.
patent: 6017693 (2000-01-01), Yates, III et al.
Aalberse and Platts-Mills, “How do we avoid developing allergy: Modifications of the TH2 response from a B-cell perspective,”J. Allergy Clin. Immunol., 2004, 113:983-986.
Akdis et al., “Skin Homing (Cutaneous Lymphocyte-Associated Antigen-Positive) CD8+T Cells Respond to Superantigen and Contribute to Eosinophilia and IgE Production in Atopic Dermatitis,”J. Immunol., 1999, 163:466-475.
Al-Ani et al., “Modified Proteinase-Activated Receptor-1 and -2 Derived Peptides Inhibit Proteinase-Activated Receptor-2 Activation by Trypsin,”J. Pharmacol. Exp. Ther., 2002, 300(2):702-708.
Alexander et al., “Leishmania mexicanaCysteine Proteinase-Deficient Mutants Have Attenuated Virulence for Mice and Potentiate a Th1 Response,”J. Immunol., 1998, 161:6794-6801.
Almeida et al., “The Capsular Polysaccharides ofCryptococcus neoformansActivate Normal CD4+T Cells in a Dominant Th2 Pattern,”J. Immunol., 2001, 167:5845-5851.
Bachert et al., “Total and specific IgE in nasal polyps is related to local eosinophilic inflammation,”J. Allergy Clin. Immunol., 2001, 107:607-614.
Beaumont et al., “Volumetric Aerobiological Survey of Conidial Fungi in the North-East Netherlands. II. Comparison of Aerobiological Data and Skin Tests with Mould Extracts in an Asthmatic Population,”Allergy, 1985, 40:181-186.
Benninger et al., “Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology,”Otolaryngol. Head Neck Surg., 2003, 129:S1-S32.
Benninger et al., “Diagnosis and treatment of uncomplicated acute bacterial rhinosinusitis: Summary of the Agency for Health Care Policy and Research evidence-based report,”Otolaryngol. Head Neck Surg., 2000, 122:1-7.
Bousquet et al., “Allergic rhinitis: A disease remodeling the upper airways?”J. Allergy Clin. Immunol., 2004, 113:43-49.
Braunstahl et al., “Segmental Bronchial Provocation Induces Nasal Inflammation in Allergic Rhinitis Patients,”Am. J. Respir. Crit. Care Med., 2000, 161:2051-2057.
Brescianai et al., “Rhinosinusitis in severe asthma,”J. Allergy Clin. Immunol., 2001, 107:73-80.
Bush and Prochnau, “Alternaria-induced asthma,”J. Allergy Clin. Immunol., 2004, 113:227-234.
Buzina et al., “Fungal biodiversity—as found in nasal mucus,”Medical Mycology, 2003, 41:149-161.
Catten et al., “Detection of Fungi in the Nasal Mucosa Using Polymerase Chain Reaction,”Laryngoscope, 2001, 111:399-403.
Cho et al., “A High Throughput Targeted Gene Disruption Method forAlternaria brassicicolaFunctional Genomics Using Linear Minimal Element (LME) Constructs,”Molecular Plant-Microbe Interact., 2006, 19:7-15.
Cody et al., “Allergic Fungal Sinusitis: The Mayo Clinic Experience,”Laryngoscope, 1994, 104:1074-1079.
Compton, “Glycosylation and Proteinase-Activated Receptor Function,”Drug Dev Res., 2003, 59:350-354.
Conte, Jr. et al., “Intrapulmonary Pharmacokinetics and Pharmacodynamics of Itraconazole and 14-Hydroxyitraconazole at Steady State,”Antimicrobial Agents and Chemotherapy, 2004, 48(10):3823-3827.
Corey et al., “Allergic fungal sinusitis: Allergic, infectious, or both?”Otolaryngol. Head Neck Surg., 1995, 113:110-119.
Corren et al., “Changes in bronchial responsiveness following nasal provocation with allergen,”J. Allergy Clin. Immunol., 1992, 89:611-618.
Cramer and Lawrence, “Identification ofAlternaria brassicicolagenes expressed in planta during pathogenesis ofArabidopsis thaliana,” Fungal Genet. Biol., 2004, 41:115-128.
Cramer et al., “Bioinformatic analysis of expressed sequence tags derived from a compatibleAlternaria brassicicola-Brassica oleraceainteraction,”Mol. Plant Pathol., 2006, 7(2):113-124.
Dash et al., “Structural and Mechanistic Insight into the Inhibition of Aspartic Proteases by a Slow-Tight Binding Inhibitor from an ExtremophilicBacillussp.: Correlation of the Kinetic Parameters with the Inhibitor Induced Conformational Changes,”Biochemistry, 2001, 40:11525-11532.
Davis and Kita, “Pathogenesis of chronic rhinosinusitis: role of airborne fungi and bacteria,”Immunol. Allergy Clin. N. Am., 2004, 24:59-73.
Denning et al., “The link between fungi and severe asthma: a summary of the evidence,”Eur. Respir. J., 2006, 27:615-626.
deShazo and Swain, “Diagnostic criteria for allergic fungal sinusitis,”J. Allergy Clin. Immunol., 1995, 96:24-35.
Eichel, “A Proposal for a Staging System for Hyperplastic Rhinosinusitis Based on the Presence or Absence of Intranasal Polyposis,”Ear Nose Throat J., 1999, 78:262-265.
Eisenbarth et al., “Lipopolysaccharide-enhanced, Toll-like Receptor 4-dependent T Helper Cell Type 2 Responses to Inhaled Antigen,”J. Exp. Med., 2002, 196(12):1645-1651.
Fadel et al., “Alternaria spore and mycelium sensitivity in allergic patients: in vivo and in vitro studies,”Ann. Allergy, 1992, 69:329-335.
Faveeuw et al., “Schistosome N-glycans containing core α3-fucose and core β2-xylose epitopes are strong inducers of Th2 responses in mice,”Eur. J. Immunol., 2003, 33:1271-1281.
Flotow et al., “Development of a Plasmepsin II Fluorescence Polarization Assay Suitable for High Throughput Antimalarial Drug Discovery,”J. Biomol. Screen., 2002, 7(4):367-371.
Fokkens et al., “EAACI Position Paper on Rhinosinusitis and Nasal Polyps Executive Summary,”Allergy, 2005, 60:583-601.
Galagan et al., “Sequencing ofAspergillus nidulansand comparative analysis withA. fumigantsandA. oryzae,” Nature, 2005, 438:1105-1115.
Gliklich and Metson, “The health impact of chronic sinusitis in patients seeking otolaryngologic care,”Otolaryngol. Head Neck Surg., 1995, 113:104-109.
Godthelp et al., “Dynamics of nasal cosinophils in response to a nonnatural allergen challenge in patients with allergic rhinitis and control subjects: a biopsy and brush study,”J. Allergy Clin. Immunol., 1996, 97:800-811.
Gonzalo et al., “Eosinophil Recruitment to the Lung in a Murine Model of Allergic Inflammation. The Role of T Cells, Chemokines, and Adhesion Receptors,”J Clin Invest., 1996, 98(10):2332-2345.
Gottlieb, “Relation of intranasal disease in the production of bronchial asthma,”JAMA, 1925, 85(2):105-108.
Green et al., “Allergen detection from 11 fungal species before and after germination,”J. Allergy. Clin. Immunol., 2003, 111:285-289.
Hamilos et al., “Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis,”J. Allergy Clin. Immunol., 1995, 96:537-544.
Hamilos, “Chronic sinusitis,”J. Allergy Clin. Immunol., 2000, 106:213-227.
Hansen et al., “Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation,”J. Clin. Invest., 1999, 103(20:175-183.
Harlin et al., “A clinical and pathologic study of chronic sinusitis: The role of the eosinophil,”J. Allergy Clin. Immunol., 1988, 81:867-875.
Heaton et al., “An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children,”Lancet, 2005, 365:142-149.
Hoover et al., “Chronic sinusitis: Risk factors for extensive
Kita Hirohito
Lawrence Christopher B.
Ponikau Jens
Fish & Richardson P.C.
Graser Jennifer E
Mayo Foundation for Medical Education and Research
Virginia Tech Intellectual Properties Inc.
LandOfFree
Fungus-induced inflammation and eosinophil degranulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fungus-induced inflammation and eosinophil degranulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fungus-induced inflammation and eosinophil degranulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2647244